MedCity News October 31, 2025
Marissa Plescia

Eli Lilly’s LillyDirect platform is partnering with Walmart to let patients pick up prescriptions for its GLP-1 drug Zepbound at Walmart pharmacies, expanding access beyond home delivery.

Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound through LillyDirect, marking LillyDirect’s first retail collaboration.

LillyDirect is Eli Lilly’s direct-to-consumer digital healthcare platform and online pharmacy service. It offers access to medications for patients living with obesity, migraines and diabetes. Patients have the choice to use their insurance or self-pay for certain medications.

Typically, patients accessing Zepbound through LillyDirect receive free home delivery, but the partnership with Walmart gives them the option to pick it up at their local Walmart pharmacy as well. Those...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech, Provider, Retailer
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal

Share Article